Skip to main content

Table 4 The total costs (USD) in the adjuvant treatment of premenopausal patients with stage Ia to IIIa breast cancer in Taiwan

From: Cost-utility analysis of adjuvant goserelin (Zoladex) and adjuvant chemotherapy in premenopausal women with breast cancer

  Drug Costs Surgery G-CSF Treatment Blood Testing Chemo Costs Total Costs
  BSA 1.5 m2 BSA 1.8 m2      BSA 1.5 m2 BSA 1.8 m2
Goserelin 5,532 0 0 0 0 5,532
Chemotherapy         
   CMF 149 156 438 651 59 492 1,789 1,795
   FEC 1,964 1,970 438 651 59 492 3,603 3,610
   TE 10,813 12,145 438 651 59 492 12,453 13,785
   TEC 10,878 12,210 438 651 59 492 12,517 13,849
  1. BSA, body surface area; CMF, (cyclophosphamide, methotrexate, 5-fluorouracil); FEC, (5-fluorouracil, epirubicin, cyclophosphamide); TE (docetaxel, epirubicin); TEC, (docetaxel, epirubicin, cyclophosphamide)